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ANTIBIOTICS AND FUNGOUS INFECTIONS*
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AND RICHARD STRAUSS, M.D.
Undesirable side reactions to the broad spectrum antibiotics such as aureo-
mycin and chioramphenicol are not uncommon. These are referable principally to
the oral mucous membranes and the gastro-intestinal tract. Many types of re-
actions have been noted; these include: sore tongue, sore mouth and throat,
black hairy tongue, angular stomatitis, rectal and vaginal irritation (redness,
fissuring, bleeding), glossitis, pruritus vulvae et ani, diarrhea, nausea and vomit-
ing, etc. Of these, oral signs and symptoms appear to occur most often and present
the most troublesome problem. Oral manifestations have been noted in 6 to 20%
of individuals receiving aureomycin and chioramphenicol (1—2). Similar side re-
actions may occur following penicillin therapy but are not common enough to
constitute a problem.
Various explanations have been offered for these reactions. Some consider
that they are an expression of moniliasis, a fungous infection caused by Candida
albicans (3—4). This organism has in fact been commonly isolated from indi-
viduals with inflammatory side reactions. The possibility of superimposed fungous
infections, moniliasis in particular, is held to be a definite threat of antibiotic
therapy. The Food and Drug Administration requires appropriate warnings to
be placed on the containers of the newer orally administered antibiotics. In-
cidentally, very unusual fungous infections such as endocarditis due to species
of Candida and Aspergillus have been implicated in relation to antibiotic therapy
(5—6). Other investigators hold that the side reactions are characteristic of vita-
min B deficiency (7—8). Harris, who first detailed the features of such side re-
actions, postulates a combination of causes. According to his thesis, the anti-
biotics may induce an acute vitamin B deficiency which in turn predisposes to
superimposed moniliasis (9). As a matter of fact, the incrimination of vitamin B
deficiency and/or moniliasis is largely based on clinical resemblances and not
on definitive laboratory findings.
The objective of the present preliminary report is to define the possible role
of Candida albicans in the production of side reactions to antibiotics.
Fungous Flora of the Mouth and Rectum During Antibiotic Therapy
The administration of broad spectrum antibiotics does not bring about sterility of the
mouth and gastro-intestinal tract. Properly speaking, a new flora is established which
represents those organisms not susceptible to the antibiotic. A short course of aureomycin
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therapy, for instance, will bring about a sharp decrease of the predominantly gram posi-
tive throat flora and permit the development of a predominantly gram negative flora (10).
The total number of organisms is markedly decreased, however, during and after this
conversion. In other words, susceptible organisms are rapidly eliminated and non-sus-
ceptible ones are enabled to become dominant. The same phenomenon occurs with penicil-
lin therapy except that unlike the effect of aureomycin, coliform organisms and
Hemophilus become established in the throat after the gram positives are eliminated (11).
With penicillin, the total number of throat organisms is not nearly so diminished as with
aureomycin and chloramphenicol. Because of the resistance of Proteus and Pseudomonas
as well as many strains of coliform organisms, the "sterilizing" effect of the newer anti-
biotics on the bowel flora is not particularly striking.
The effect of antibiotics on the fungous flora has not been specifically investigated.
Meads and his co-workers mention incidentally that following aureomycin therapy Candida
species could be isolated in about 20% of patients although none were isolated prior to ther-
apy (10). Ordinarily, fungi make up an inconsequential part of the respiratory and gastro-
intestinal flora. Species of Candida are most commonly isolated and these not in great num-
bers. These yeast-like fungi are part of the normal flora. Candid albicans is the principal
species of the group which may become pathogenic. It is also the commonest. It has been
isolated from 6—24% of normal mouths in different surveys (15—17). Generally, only a few
colonies can be isolated from the throat and feces in culture studies made in a routine man-
ner. Species of Cryptococcus and Geotrichum may inhabit the bowel but are ordinarily
present in lesser numbers than Candida organisms. Schnoor was able to isolate Candida
species from 33% of 314 stool cultures (18). About half of the isolated species were Candida
albicans. Benham and Hopkins also found Candida species in about one-third of the stools
cultured (15).
Experimental
The following procedure was used to determine the influence of antibiotic
therapy on the incidence of Candida species in the mouth and rectum: cultures
from the mouth and rectum were secured with a sterile cotton swab dipped in
brain heart infusion broth. In the mouth the swab was rubbed vigorously over
the pharynx, tongue, and in the gutters between the teeth and buccal mucosa.
An additional swab was inserted deeply into the rectum with a twisting motion
in an effort to collect fecal material. The swabs were then streaked over plates
containing dextrose-peptone medium (Sabouraud-like agar) to which 50 units
each of penicillin and streptomycin had been added. No effort was made specifi-
cally to identify any species of Candida except Candida albicans. The others
(C. tropicalis, C. pseudotropicalis, C. krusei, C. parakrusei, etc.) were simply
grouped as Candida species. The individuals sampled were collected at random
from the wards of the University Hospital. Speciemens were not taken from per-
sons unless they had received antibiotics for at least 4 days. The results are
shown in Tables I and II.
The normal incidence of C. albicans among untreated individuals in this series
was approximately 7.5%. In general, an individual harboring C. albicans in his
mouth also had this organisn in his rectum. The administration of penicillin
exerted a sufficient influence on the normal flora to enable C. albicans to be iso-
lated somewhat more often than in the control group; however, a striking in-
crease of positive isolations occurred in the group receiving aureomycin or chioro-
mycetin. Species of Candida were isolated from four-fifths of the individuals in
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this latter group. Approximately 80% of these yeast-like fungi were C. albicans.
Not only was there a much greater percentage of individuals harboring this or-
ganism, but in almost every case there were rather large numbers of organisms
present. Ordinarily, less than 5 yeast-like colonies appear on the primary isola-
tion plates prepared from samples taken from normal, untreated individuals.
Antibiotic-treated individuals frequently exhibited hundreds of colonies on their
primary plate, although this effect was distinctly less with penicillin than with
aureomycin or chloromycetin. This is in keeping with the smaller or lesser effect
of penicillin on the mouth and gastro-intestinal flora.
Species of Cryptococcus and Geotrichum were rarely encountered in this small
series. No effort was made to record mucous membrane changes in those receiving
chloromycetin or aureomycin. On the other hand only 1 clear-cut case of clinical
thrush was observed.
The In Vitro and In Vivo Stimulation of Fungi by Antibiotics
Evidence has been recorded that certain antibiotics directly stimulate fungus metabolism
and thereby effect an increased rate of growth. Campbell and Saslow found that streptomy-
ciii enhanced the in vitro growth of various systemic and superficial fungi although such an
effect could not be confirmed in vivo (19, 20). Foley and Winter reported that penicillin G
increased the mortality rate of chick embryos infected with C. stellatoidea, although in this
case, it was not possible to demonstrate any in vitro stimulation by penicillin (21). Penicil-
lin did not increase the death rate when C. albicans was inoculated onto the chorioallantoic
membrane. These investigators find penicillin to have an adverse effect on rabbits intra-
venously infected with C. stellatoidea. Pppenfort and Schnall demonstrated a marked in
vitro growth enhancement of C. albicans and Cryptococcus neoformans growing in Sabou-
raud's medium (4). These investigators found that a few drops of 2.5% aureomycin solution
put into a cylinder on Sabouraud's agar in which the fungus cells were suspended yielded a
greatly increased growth around the cylinder. This was attributed to the diffusion of some
stimulatory substance out of the cylinder. Crystalline aureomycin failed to give this effect.
The stimulation was observed only when the solution was made up from the contents of
aureomycin capsules such as are used for the oral administration of this drug. Since aureo-
mycin is ordinarily administered in capsules, the authors imply a connection here.
Experimental
This work was repeated in the present study using C. albicans, C. stellatoidea
and Cry ptococcus neoformans as test organisms. The cells were suspended in
Sabouraud's agar (1% peptone, 2% glucose) and the drugs applied in 0.1 cc.
quantities to filter disks placed on the surface of the medium according to a
method previously described (22). This is a diffusion method essentially similar
to the one used by Pappenfort and Schnall.
The results are shown in Table III. None of the crystalline antibiotics ex-
hibited any stimulatory effect. The aureomycin solution prepared from capsules
did, however, give a definite stimulation which increased with the concentration
used. According to information elicited from the manufacturer, the inert diluent
or carrier present in capsules for oral use contained dibasic calcium phosphate.
When this relatively insoluble salts was used alone the stimulatory effect was
immediately evident. Calcium chloride solution did not exhibit such an effect
but dibasic sodium phosphate did. This clearly identifies the phosphate ion as
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the substance responsible for the stimulation. The larger zones of stimulation
attained with dibasic sodium phosphate are simply a result of the greater solubil-
ity of this salt. Aureomycin itself has nothing to do, obviously, with the stim-
ulatory effect.
These data can be interpreted in a more explicit fashion still: the medium
used (Sabouraud's) is patently deficient in phosphorous, an element strongly
required by fungi. The phosphate salt added to the ifiter paper simply corrected
this deficiency. That this was actually the case was shown by repeating the ex-
periment with different media. No stimulation could be detected in the following
media with the same drugs listed in Table III: heart infusion agar, Difco blood
TABLE III
Effect of antibiotics and phosphate salts on yeast like fungi
(Filter disk diffusion method)
ZONE OF STIMULATION IN MM.
AGENT CONCENTRATION
C. olbicans C. steUatoidea
%
Streptomycin 0.5 0 0 0
Chioromycetin 0.5 0 0 0
Penicillin G 0.5 0 0 0
Terramycin 0.5 0 0 0
Crystalline Aureomycin 0.5 0 0 0
Crystalline Aureomycin 1.0 0 0 0
Aureomycin (from capsule for oral
administration) 0.5 22 16 16
Aureomyein (from capsule for oral
administration 2.0 SO 26 26
CaHPO4 0.5 20 18 22
CaHPO4 1.0 18 22 22
Na2HPO4 0.5 40 42 40
Na2HPO4 1.0 48 46 50
CaCl. 0.5 0 0 0
agar base, corn meal agar. These media evidently contain sufficient quantities of
phosphate so that this ion is not limiting. Moreover, when 1% dibasic sodium
phosphate was added to Sabouraud's dextrose medium, the stimulatory effect
of aureomycin from the capsule or of added phosphate was no longer present.
The following, more precise method was employed to detect any slight stimu-
latory effect these antibitotics might have on C. albicans. The liquid medium
used contained the following ingredients in grams per liter: asparagine 5.0,
glucose 10.0, MgSO4 0.5, and KH2PO4 2.0. One-tenth ml. quantities of a 3 day
old culture of C. albicans, variously diluted, were added to 9.9 ml. quantities of
broth tubes containing different concentrations of antibiotic. The tubes were
incubated at 37°C. The amount of growth in each tube was recorded turbidometri-
cally. The results are shown in Table IV. There was no evidence of stimulation
in any case.
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Effect of Antibiotics on Experimental Moniliasis in Mice
The mouse is generally not considered susceptible to infection with C. albicans. The
rabbit is described as the animal of choice. This may require revision in the light of recent
studies. Strauss and Kligman found that the intraperitoneal inoculation of this organism
suspended in gastric mucin regularly resulted in death (23). Moreover, the intravenous
inoculation of C. albicans is rapidly lethal (24). Kidney lesions result which are similar to
thos responsible for the death of rabbits. The intraperitoneal injection of cells suspended
in saline results in an erratic infection of variable severity. Usually within a week a few
small, whitish plaques or nodules develop over the diaphragm and variously on the pen-
toneal surfaces of the viscera, particularly along the greater curvature of the stomach, the
spleen and the kidneys. Occasionally, a great many nodules are distributed on the surface
and throughout the greatly enlarged kidneys. The kidney is the most susceptible organ.
Its extensive involvement is responsible for the approximately 10% death rate which results
from the intraperitoneal injection of this organism. About 20% of the mice fail to show le-
sions; thus, the mouse is variably susceptible to C. albicans when the cells are injected intra-
peritoneally in saline. The objective of the following experiment was to determine whether
antibiotic therapy could enhance the infection so as to produce a more constant or more
severe infection.
TABLE IV
Effect of antibiotics on growth of Candida albicans
(Spectrophotometnic readings at 4 days. Light source, 640 mgi)
DILUTION OF 3 CAY OLD
C. albicans CULTURE
CONT
sa inc
ROL
Medium
only
AUREOMY
0.1 1.0
7/CC. 7/CC.
80.3 82
CIN
10
7/CC.
85
TERRAMYCIN
0.1 1.0 10
7/CC. 7/CC. 7/CC.
79.5 84 81
PEE
0.1
7/CC.
82
ICILLXN C
1.0 10
7/CC. 1/CC.
81 83
CHLOROMYCEUN
0.1 1.0 10
7/CC. 7/CC. 7/CC.
81 84.5 81Undiluted* 98 81
1—1000 99.5 82 83.0 83 85 84 86 87 83 86 83 84 85.0 85
1—50,000 99 85 87.0 84 85 86.5 87 88 84 86 84 84.587 87
* One tenth ml. of the undiluted culture contained approximately 8,000 cells.
Experimental
Twenty gram, white, male mice were used. All were infected intraperitoneally
with 0.5 cc. of a 1:100 volumetric suspension of C. albicans cells harvested from
a 3 to 5 day growth on dextrose-peptone medium. The experiment was termi-
nated in 10 days. The antibiotics were given either orally or by intraperitoneal
injection. The oral administration was effected by allowing the mice to drink a
prescribed solution of the antibiotic after previously determining how much the
mice would drink of each solution in a 24 hour period. The oral intake was thus
somewhat variable from day to day but over a period of days averaged out rather
closely with the calculated intake. Fresh antibiotic solutions were offered the
mice daily. The results are shown in Table V.
The mortality rate was not adversely affected to a significant degree by the
oral or intraperitoneal administration of any antibiotic in any of the schedules
used. At autopsy, the same degree of variable infection was observed in the mice
given oral antibiotics as in the control mice. In about 15% of the survivors there
was parenchymatous kidney involvement which ranged from a few small nodules
to a great many distributed throughout the kidney cortex. An impression was
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gained that in the mice given aureomycin and chioramphenicol intraperitoneally
the lesions, if present at all, seemed to be somewhat more numerous and the in-
fection more severe. Nonetheless, a significant number of mice given these latter
antibiotics intraperitoneally did not show any lesions as in the controls. Further
work is necessary to settle this more conclusively.
Mice do not develop an infection when their drinking water for 10 days con-
tains a 1:1000 volumetric suspension of C. albicans cells prepared fresh daily.
This negative result was not altered when the cells were suspended in the various
antibiotic solutions (aureomycin, chioramphenicol and terramycin) which were
used for drinking water when the average daily dose imbibed was approximately
TABLE V
Influence of antibiotics on mortality of mice infected with C. albicans
Mice infected intraperitoneally with 0.5 cc of a 1:100volumetric suspension of
C. albicans cells
DEUG ROUTE DOSE P5.R 24 HiS. METHOD
Aureomycin oral 100 mg/kilo Daily for 4 days 24 3/24
Aureomycin oral 100 mg/kilo Daily for 10 days 24 2/24
Aureomycin oral 100 mg/kilo Daily for 15 days starting 5
days before inoculation
24 4/24
Aureomycin I.P. 50 mg/kilo Once daily for 10 days 24 1/24
Aureomycin I.P. 100 mg/kilo Once daily for 10 days 24 3/24
Aureomycin I.P. 100 mg/kilo Two injections of 50 mg/kilo
daily for 10 days
24 4/24
Chloramphenicol Oral 100 mg/kilo Daily for 10 days 24 1/24
Chloramphenicol I.P. 100 mg/kilo Once daily for 10 days 24 5/24
Terramycin Oral 100 mg/kilo Daily for 10 days 24 4/24
Terramycin I.P. 100 mg/kilo Once daily for 10 days 24 1/24
Saline Control I.P. 0.5 cc P.SS Once daily for 10 days 60 6/60
100 mg./kilo of antibiotic. Thus, there was no clear cut evidence in any of these
experiments that the administration of antibiotics enhanced the infection.
Discussion
The cause of the oral and muco-cutaneous side reactions to the wide spectrum
antibiotics is not known. Of the theories that have been proposed none have been
supported convincingly by experimental evidence. As a matter of fact, the in-
adequacies of these theories are more apparent than their positive aspects.
Role of Fun gous Infections
The muco-cutaneous side reactions have been ascribed to moniliasis by some
investigators. Perhaps the criteria for making this diagnosis would not satisfy
the requirements of those experienced in medical mycology. Some observers
would appear to believe that the isolation of Candida albicans in the presence of
stomatitis and glossitis is tantamount to making a diagnosis of moniliasis. Such
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a conclusion is unjustified. This organism may be part of the normal flora. It
becomes abundant in the oral and rectal flora of the majority of individuals re-
ceiving aureomycin or chioromycetin. Despite this, relatively few individuals
develop any side reaction which could be putatively attributed to monilia.sis.
As a matter of fact unless the clinical picture is quite characteristic it is often
extremely difficult to establish such a diagnosis. Certainly, the mere isolation
of the organism has no great diagnostic value. The clinical picture of thrush is
typical since the creamy white patches which occur contain enormous numbers of
organisms on direct microscopic examination. The finding of lesions which
present classical features to those with experience and from which scrapings show
a plentiful quantity of organisms microscopically offers a greater certainty in
diagnoses. The glossitis and stomatitis usually described as a side reaction would
not appear to have such features and microscopic studies have generally not
been performed. Exceeding difficulties attend the diagnosis of broncho-pulmonary
moniliasis. Such a diagnosis cannot be made lightly and other possible causes
must first be excluded. In our own series, no cases of clinical thrush were en-
countered. It is likely, however, that the incidence of thrush has increased in
patients receiving these antibiotics. Personal experience indicates this. Williams
clearly identified such cases in the patients he observed with side reactions to
chioramphenicol (2). On the other hand, in our experience, patients diagnosed
as having moniliasis because of oral inflammatory reactions, have not satisfied
our criteria for making this diagnosis. Significantly, our own observations and
those of Williams indicate that thrush is more likely to develop in individuals
with underlying disease or in elderly individuals in poor health (2). This accords
with a basic principle in medical mycology which ascribes a low order of viru-
lence to many of the fungi causing systemic disease. Often the development of
a mycosis depends upon some illness which lowers the host resistance. Thus, the
way is paved for even normal endogerious organisms to become parasitic and
produce disease. It is clear from the data presented that the opportunity for
monilial infection is greater in individuals receiving wide spectrum antibiotics
owing to the great increase in their fungous flora. When the hosi resistance is de-
pressed by primary surgical and medical conditions, as well as by old age itself,
the large number of potentially pathogenic organisms present may predispose to
infection. The actual development of this complication would appear, however,
to be relatively uncommon since the overwhelming majority of patients treated
with antibiotics do not develop moniliasis. Actually, this problem is not a new
one. An analogue to this situation has been previously encountered in penicillin
therapy. The administration of penicillin brings about a conversion of a pre-
dominantly gram positive throat flora to a gram negative one (11). Somner and
Favour recorded four individuals with recurrent respiratory diseases or with
severe surgical complications in whom the administration of penicillin led to the
eventual development of broncho-pneumonia due to penicillin insensitive gram
negative organisms (25). Two of the patients with this type of superinfeetion
died. In the other two cure of the superinfection was effected by using another
antibiotic (streptomycin) to which the emergent flora were susceptible. Somner
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and Favour appropriately point out that the complication of superinfection is
more likely in debilitated, ill people. Others have noted superinfections conse-
quent to penicillin and streptomycin therapy (26-28). In summarizing this
situation one might estimate that an individual with a really serious disease may,
if his resistance is poor enough, acquire an additional infection by the organisms
resistant to the administered antibiotic.
Zimmerman includes in his report a personal communication from Dr. Farber
of Boston who has had the opportunity of observing 7 cases of disseminated
moniliasis in children who were receiving penicillin and aureomycin (6). In these
cases the evidence of moniliasis is indisputable. However, 5 of these individuals
had leukemia. Farber calls attention to the fact that moniliasis was not seen in
leukemic patients prior to the antibiotic era and evidently feels on this account
that antibiotic therapy is responsible for this complication. In our estimation,
this is only partially true. It is necessary to consider that advances in anti-
leukemic therapy and the use of antibiotics has greatly extended the lives of
such patients. Leukemia patients have a death-dealing disease and are, as a
consequence, more susceptible to various infectious agents. Previously, many
died with bacterial infections. This can now be largely prevented by antibiotic
treatment. This naturally increases the opportunity for antibiotic resistant or-
ganisms such as fungi to establish infections which contribute to the demise of
such patients. It is essential not to attribute an etiologic role to associated phe-
nomena. One must often think in terms of causal networks rather than single
causes. Perhaps a majority of patients hospitalized for surgery are now receiving
antibiotic therapy in one form or another regardless of the particular cause for
admission. One could thus unjustifiably attribute to the antibiotic therapy a
'ausal role for many complications simply on the basis that most individuals will
hwe received such therapy. It is particularly in individuals with chronic illnesses
that antibiotics are likely to be administered so that this particular "cause" is
almost always available for explaining undesirable sequelae. The 2 cases of
Aspergillus endocarditis reported by Zimmerman in which it was considered that
the administration of penicillin may have possibly played a role furnish an
example of this problem. One had rheumatic fever and the other a traumatic
leg injury requiring amputation followed by failure to heal. It is a distinct pos-
sibility that in these individuals with chronic disorders the fungous infection
would have occurred independently of penicillin therapy.
The present data furnish no evidence that antibiotics directly stimulate the
growth of Candida albicans. On the other hand, Foley and Winter report an
increased death rate in penicillin treated chick embryos infected via the chorio-
allantoic membrane with Candida stellatoidea (21). This could not be demon-
strated with C. albicans In addition, in a small number of rabbits intravenously
injected with C. stellatoidea the infection appeared to be enhanced by the ad-
ministration of penicillin. This work requires confirmation and extension. We
were unable to confirm Foley's finding of an in vitro stimulation of the growth
of Cryptococeus neoformans by penicillin.
One may note that reports of cutaneous moniliasis are strikingly lacking among
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the complications of antibiotic therapy. Pruritus ani has been attributed to
moniliasis but the same objections may be raised to this as given above with ref-
erence to the existence of moniliasis in the mouth. Cutaneous moniliasis has been
described in patients with pemphigus treated with antibiotics but in these in-
stances interpretation is complicated by the simultaneous administration of
cortisone or ACTH (29). It is worth while emphasizing that a diagnosis of monilia-
sis should not be made unless direct sampling of the lesion macroscopically
shows an abundance of fungus elements.
The Role of Vitamin Deficiency
Some have regarded the muco-cutaneous signs as those of vitamin B deficiency,
particularly riboflavin and niacin deficiency. Two mechanisms have been con-
sidered: 1), the elimination of vitamin B synthesizing organisms in the intestinal
tract, and 2) metabolic antagonism between the antibiotic and the B vitamins.
This thesis has several serious objections. First of all, the glossitis and stomatitis
sometimes develops within 48 hours after the first administration of the anti-
biotic and generally within the first five days. Human experiments show clearly
that a very much longer period is required to establish such a deficiency (30).
Secondly, these symptoms have not been entirely prevented by the prophylactic
administration of vitamins in the B group nor has their therapeutic administra-
tion been regularly attended by a rapid regression of the lesions (1, 2). Further-
more, many of the side reactions to antibiotic therapy, such as vulvo-vaginitis,
rectal irritation and perineal dermatitis are not classical signs of vitamin B de-
ficiency. Deficiency disease has unfortunately become a diagnostic waste basket
for oral lesions in general.
Harris has postulated that side reactions to aureomycin represent a combina-
tion of vitamin B deficiency and moniliais (9). According to this theory, the vita-
min B deficiency increases the susceptibility to Candida infection. Evidence
for this view point is lacking.
The Role of Sensitization
Allergic cutaneous reactions to orally administered aureomycin are rare.
Erythema multiforme, urticaria and eczematous dermatitis have occasionally
been recognized (31, 32). Recently Reiches and Webb have reported 13 cases of
genitocrural pruritis in patients receiving aureomycin (33). They attribute the
pruritus to epiderrnal sensitization but offer no evidence to support their diag-
nosis of contact dermatitis. The improbability of their hypothesis is further em-
phasized by the gratifying relief obtained by their patients by the local use of
an antihistaminic ointment even in the face of continued ingestion of aureo-
mycin. The antihistaminics do not possess the property of preventing or amelio-
rating contact dermatitis. Reiches and Webb's work was not controlled. The
possibility that the oral signs are due to mucosal sensitization has to be con-
sidered. A wealth of clinical experience accumulated by dermatologists over many
years indicates that pure mucous membrane sensitization in the absence of
cutaneous lesions is extraordinarily rare (34). It is much more common for an
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ingested substance to cause lesions on the glabrous skin about the mouth or on
the lips without involving the mucous membrane at all. Obviously, the mucous
membrane is rather resistant to sensitization. The fact that the oral side reactions
may occur within 48 hours after the initial ingestion of the drug in patients not
having taken it previously argues compellingly against the possibility that sen-
sitization underlies the oral reaction. A longer time than this is ordinarily re-
quired for sensitization to occur.
Other Considerations
Munoz and Geister have established that very small concentrations of aureo-
mycin inhibit the phagocytic activity of polymorphonuclear leukocytes (35).
Although this deserves mention it is difficult to comprehend how this could ac-
count for the oral lesions except through a possible interference with the normal
mechanism of defense against infection.
The known irritant properties of aureomycin constitute an additional approach
to this problem (36). Aureomycin is irritating over a wide pH range when in-
ected intraperitoneally, intramuscularly, subcutaneously or intracutaneously.
It is interesting in this respect that the most prominent side reactions have oc-
curred in the mouth, in the rectum and around the anus. Even though the anti-
biotic capsules are swallowed before they are allowed to dissolve one may con-
sider the possibility that a sufficient concentration is secreted into the saliva to
cause irritation in certain susceptible persons. Certainly large quantities may
accumulate in the feces. Heilinan and Dearing observed concentrations as high
as 2000 micrograms per gram of feces in patients receiving 3 grams of aureomycin
daily (12). When a similar amount of terramycin is given daily as much as 5000
micrograms per gram of feces may be observed (14). Quantities as high as these
may irritate the rectal mucosa and cause leakage of antibiotic laden fluid onto
the perianal skin. The gastro-intestinal distress that may occur with aureomycin
therapy probably is a direct result of the irritation of the gastric mucosa. In this
connection it is interesting to note Fisher and Leider consider that oral reactions
to aureomycin are quite common when troches containing 15 milligrams are
administered (37). This latter medication is allowed to dissolve in the mouth.
In our own as yet inadequate experience stomatitis has been produced in a ma-
jority of individuals who take 4 such troches an hour for 2 days during the time
they are awake. The total daily dose of aureomycin on such a regimen does not
exceed 0.25 gram. The inflammatory reaction in the mouth coincides exactly
with the stomatitis observed in patients receiving aureomycin capsules. Prob-
ably, the local maintenance of a fairly high concentration of aureomycin is the
principal etiologic factor of the stomatitis. Other factors no doubt operate since
not all the subjects receiving aureomyciri troches develop a stomatitis. This is
being investigated further.
SUMMARY
1. Aureomycin, Chioromycetin, Terramycin and Penicillin did not stimulate
the in vitro growth of Candida albicans.
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2. The in vitro enhancement of the growth of Candida albicans by material
obtained from Aureomycin capsules was found to be due to the inert phosphate
content of such capsules.
3. Candida albicans was found in the mouths and rectums of the majority of
individuals who were given Aureomycin and Chioromycetin. In these individuals
large numbers of the organism were generally present.
4. There was no clear cut evidence of in vivo enhancement of moniliasis in
mice receiving various antibiotics.
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DISCUSSION
Dx. BENEDEK, Chicago: I would like to emphasize two points. First, mice
seem to be an inappropriate test object for antibiotics. Investigations prove that
there is in many instances a lack of correlations between the therapeutic results
observed in animals and those in man. Mice, for instance, infected with pneumo-
cocci respond poorly to Chloramphenicol, and yet, this antibiotic appears to
give excellent results in the treatment of pneumococcic pneumonia in man. In
tularemia, which is also of dermatological interest, the response in mice is also
poor, while the clinical disease in man is promptly cured by this antibiotic.
Second, Aureomycin and Chioramphenicol (the latter probably to a lesser ex-
tent) destroy the ecologic balance of microorganisms in the intestine by elim-
inating the autochthonous bacterial flora. The ubiquitous Candida albicans will
invade this vacuum and with a greater invasive power it spreads into the paren-
chymatous tissues, many times, with lethal outcome. Observations made in
animal experiments do not necessarily hold true for the human species.
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DR. FREDERICK REISs, New York: Mr. Chairman—It is of interest to note
that not only moniliasis has been provoked by the use of the newer antibiotics
but we have isolated recently at Bellevue a fungus which hitherto has not been
mentioned as a complication of these new antibiotics, and that is Geotrichum.
We have seen lately a few cases of bronchial geotrichosis developing during treat-
ment with Aureomycin. In addition, I would like to make a very short remark to
what is known already in relation to the amelioration produced by Vitamin B
Complex in moniliasis. I do not believe that Vitamin B Complex, in itself, would
antagonize the growth of Monilia; the well known cultural studies would annul
such an assumption. The oral administration apparently does not compare with
the parenterally administered Vitamin B which is far superior.
The question arises now, what is the explanation? I would refer to a recent
study by Stoerck (Ann N. Y. Acad. Sci. 52: 1302, 1950) who stated that pyri-
doxine may be involved in the formation of antibodies. I think that attention
should be given to that very interesting factor: that a pyridoxine deficiency may
develop during the course of administration of the various antibiotics.
DR. LIPNIK, Philadelphia: I wish to thank the discussors for their remarks.
With regard to Dr. Reiss' comment about Geotricum infection, we have also
noticed in taking cultures from patients receiving Aureomycin and others of the
newer antibiotics that we found an occasional positive culture for this organism.
DR. WILsoN, Los Angeles: I would like to comment on Dr. Kligman's paper
but first I must congratulate the University of Pennsylvania group as a whole.
I think it would be appropriate if the "Pennsylvania Polka" were to be desig-
nated as the theme song of this particular session since ten of the fifty papers
originated there. The encore should be "The Sidewalks of New York" because
seven papers originated at the New York Graduate unit. I suggest also that
although the usual male quartette sings both of these numbers in the key of B flat
(early in the evening at least) we should sing them in the key of A since that is the
grade which should be given to the research effort coming from those institutions
(applause).
